180 related articles for article (PubMed ID: 25750273)
1. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
Elhag R; Mazzio EA; Soliman KF
Anticancer Res; 2015 Mar; 35(3):1263-9. PubMed ID: 25750273
[TBL] [Abstract][Full Text] [Related]
2. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy.
Qian X; Ren Y; Shi Z; Long L; Pu P; Sheng J; Yuan X; Kang C
Mol Pharm; 2012 Sep; 9(9):2636-45. PubMed ID: 22853427
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas.
He W; Liu R; Yang SH; Yuan F
Anticancer Drugs; 2015 Mar; 26(3):293-300. PubMed ID: 25535979
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
Ananta JS; Paulmurugan R; Massoud TF
Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
[TBL] [Abstract][Full Text] [Related]
6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
7. Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death.
Kahn SA; Biasoli D; Garcia C; Geraldo LH; Pontes B; Sobrinho M; Frauches AC; Romão L; Soletti RC; Assunção Fdos S; Tovar-Moll F; de Souza JM; Lima FR; Anderluh G; Moura-Neto V
Curr Top Med Chem; 2012; 12(19):2082-93. PubMed ID: 23167797
[TBL] [Abstract][Full Text] [Related]
8. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
9. Silibinin reverses drug resistance in human small-cell lung carcinoma cells.
Sadava D; Kane SE
Cancer Lett; 2013 Oct; 339(1):102-6. PubMed ID: 23879966
[TBL] [Abstract][Full Text] [Related]
10. Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol‑resistant glioma cells via inhibition of glucose metabolism.
Guan DG; Chen HM; Liao SF; Zhao TZ
Mol Med Rep; 2015 Nov; 12(5):7705-11. PubMed ID: 26459853
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
[TBL] [Abstract][Full Text] [Related]
12. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.
Conway GE; Casey A; Milosavljevic V; Liu Y; Howe O; Cullen PJ; Curtin JF
Br J Cancer; 2016 Feb; 114(4):435-43. PubMed ID: 26882067
[TBL] [Abstract][Full Text] [Related]
13. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells.
Inaba N; Kimura M; Fujioka K; Ikeda K; Somura H; Akiyoshi K; Inoue Y; Nomura M; Saito Y; Saito H; Manome Y
Anticancer Res; 2011 May; 31(5):1653-8. PubMed ID: 21617223
[TBL] [Abstract][Full Text] [Related]
14. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
Albanese C; Alzani R; Amboldi N; Degrassi A; Festuccia C; Fiorentini F; Gravina G; Mercurio C; Pastori W; Brasca M; Pesenti E; Galvani A; Ciomei M
Br J Pharmacol; 2013 May; 169(1):156-66. PubMed ID: 23347136
[TBL] [Abstract][Full Text] [Related]
17. Fasting enhances the response of glioma to chemo- and radiotherapy.
Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Asparaginase
Sanghez V; Chen M; Li S; Chou TF; Iacovino M; Lin HJ; Lasky JL; Panosyan EH
Anticancer Res; 2018 May; 38(5):2627-2634. PubMed ID: 29715082
[TBL] [Abstract][Full Text] [Related]
19. Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M; Lefranc F; Mijatovic T; Debeir O; Haibe-Kains B; Bontempi G; Decaestecker C; Kiss R; Mathieu V
Toxicol Appl Pharmacol; 2008 Jun; 229(2):172-83. PubMed ID: 18313712
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
